LadRx Corporation Logo

LadRx Corporation

CYTR

(2.0)
Stock Price

0,09 USD

-118.23% ROA

188.38% ROE

-0.01x PER

Market Cap.

0,00 USD

8.65% DER

0% Yield

-4655781.25% NPM

LadRx Corporation Stock Analysis

LadRx Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

LadRx Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (3121.56%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

The stock's low PBV ratio (0.01x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (26%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Assets Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

5 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

6 ROA

The stock's ROA (-592.64%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

LadRx Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

LadRx Corporation Technical Stock Analysis
# Analysis Recommendation

LadRx Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

LadRx Corporation Revenue
Year Revenue Growth
1987 700.000
1988 900.000 22.22%
1989 500.000 -80%
1990 1.100.000 54.55%
1991 4.800.000 77.08%
1992 2.500.000 -92%
1993 4.500.000 44.44%
1994 2.500.000 -80%
1995 2.500.000 0%
1996 2.900.000 13.79%
1997 14.300.000 79.72%
1998 1.300.000 -1000%
1999 823.000 -57.96%
2000 3.327.858 75.27%
2001 4.399.410 24.36%
2002 1.341.909 -227.85%
2003 94.000 -1327.56%
2004 428.164 78.05%
2005 184.360 -132.24%
2006 2.065.702 91.08%
2007 7.459.038 72.31%
2008 6.266.150 -19.04%
2009 9.500.397 34.04%
2010 100.000 -9400.4%
2011 250.000 60%
2012 100.000 -150%
2013 300.000 66.67%
2014 100.000 -200%
2015 100.000 0%
2016 200.000 50%
2017 100.000 -100%
2018 250.000 60%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

LadRx Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1987 0
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 6.800.000 100%
1995 7.100.000 4.23%
1996 3.100.000 -129.03%
1997 5.600.000 44.64%
1998 7.300.000 23.29%
1999 12.812.000 43.02%
2000 1.962.171 -552.95%
2001 1.844.038 -6.41%
2002 767.102 -140.39%
2003 4.387.599 82.52%
2004 6.012.903 27.03%
2005 9.087.270 33.83%
2006 9.781.007 7.09%
2007 18.823.802 48.04%
2008 10.465.591 -79.86%
2009 7.541.998 -38.76%
2010 8.506.937 11.34%
2011 15.491.301 45.09%
2012 12.684.793 -22.12%
2013 17.500.469 27.52%
2014 36.677.706 52.29%
2015 43.395.574 15.48%
2016 35.930.212 -20.78%
2017 19.840.106 -81.1%
2018 388.841 -5002.37%
2019 403.006 3.51%
2020 799.577 49.6%
2021 0 0%
2022 0 0%
2023 58.500.000 100%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

LadRx Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1987 3.500.000
1988 6.000.000 41.67%
1989 2.100.000 -185.71%
1990 1.300.000 -61.54%
1991 2.500.000 48%
1992 5.000.000 50%
1993 7.700.000 35.06%
1994 3.500.000 -120%
1995 3.500.000 0%
1996 4.500.000 22.22%
1997 8.800.000 48.86%
1998 2.500.000 -252%
1999 3.784.000 33.93%
2000 2.245.229 -68.54%
2001 3.416.212 34.28%
2002 0 0%
2003 0 0%
2004 0 0%
2005 366.753.000 100%
2006 9.657.257.000 96.2%
2007 14.822.142.000 34.85%
2008 10.932.522.000 -35.58%
2009 9.127.845.000 -19.77%
2010 8.235.993.000 -10.83%
2011 7.317.169.000 -12.56%
2012 8.353.000 -87499.29%
2013 10.274.000 18.7%
2014 12.845.000 20.02%
2015 19.665.000 34.68%
2016 15.991.000 -22.98%
2017 12.502.000 -27.91%
2018 8.080.000 -54.73%
2019 7.438.000 -8.63%
2020 6.001.000 -23.95%
2021 5.966.000 -0.59%
2022 4.545.884.000 99.87%
2023 3.302.752.000 -37.64%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

LadRx Corporation EBITDA
Year EBITDA Growth
1987 -1.800.000
1988 -4.100.000 56.1%
1989 -4.300.000 4.65%
1990 -800.000 -437.5%
1991 2.600.000 130.77%
1992 -2.400.000 208.33%
1993 -3.000.000 20%
1994 -7.300.000 58.9%
1995 -10.100.000 27.72%
1996 -5.100.000 -98.04%
1997 -5.200.000 1.92%
1998 -5.800.000 10.34%
1999 -14.973.000 61.26%
2000 -30.252 -49394.25%
2001 -345.092 91.23%
2002 -5.047.024 93.16%
2003 -17.842.470 71.71%
2004 -16.288.338 -9.54%
2005 -14.875.765 -9.5%
2006 -16.379.120 9.18%
2007 -21.577.714 24.09%
2008 -25.548.138 15.54%
2009 -4.844.150 -427.4%
2010 516.126 1038.56%
2011 -14.231.032 103.63%
2012 -17.848.337 20.27%
2013 -47.363.438 62.32%
2014 -29.934.253 -58.22%
2015 -58.268.741 48.63%
2016 -47.479.113 -22.72%
2017 -30.525.109 -55.54%
2018 -10.967.652 -178.32%
2019 -7.141.230 -53.58%
2020 -6.469.666 -10.38%
2021 -13.145.863 50.79%
2022 -4.545.884.000 99.71%
2023 -3.361.252.000 -35.24%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

LadRx Corporation Gross Profit
Year Gross Profit Growth
1987 700.000
1988 900.000 22.22%
1989 -1.700.000 152.94%
1990 400.000 525%
1991 4.800.000 91.67%
1992 2.500.000 -92%
1993 4.600.000 45.65%
1994 2.800.000 -64.29%
1995 1.700.000 -64.71%
1996 1.300.000 -30.77%
1997 7.900.000 83.54%
1998 1.600.000 -393.75%
1999 606.000 -164.03%
2000 3.377.793 82.06%
2001 4.328.909 21.97%
2002 1.330.622 -225.33%
2003 94.000 -1315.56%
2004 428.164 78.05%
2005 184.360 -132.24%
2006 2.065.702 91.08%
2007 7.459.038 72.31%
2008 6.266.150 -19.04%
2009 9.500.397 34.04%
2010 100.000 -9400.4%
2011 250.000 60%
2012 100.000 -150%
2013 300.000 66.67%
2014 100.000 -200%
2015 100.000 0%
2016 200.000 50%
2017 100.000 -100%
2018 250.000 60%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

LadRx Corporation Net Profit
Year Net Profit Growth
1987 -2.100.000
1988 -4.700.000 55.32%
1989 -4.800.000 2.08%
1990 -900.000 -433.33%
1991 2.500.000 136%
1992 -100.000 2600%
1993 -3.200.000 96.88%
1994 -7.700.000 58.44%
1995 -10.700.000 28.04%
1996 -5.800.000 -84.48%
1997 -6.000.000 3.33%
1998 -6.300.000 4.76%
1999 -15.041.000 58.11%
2000 -348.102 -4220.86%
2001 -931.341 62.62%
2002 -6.175.636 84.92%
2003 -17.844.600 65.39%
2004 -16.392.189 -8.86%
2005 -15.092.860 -8.61%
2006 -16.751.824 9.9%
2007 -21.889.943 23.47%
2008 -27.046.121 19.06%
2009 -4.800.308 -463.42%
2010 408.460 1275.22%
2011 -14.424.545 102.83%
2012 -17.963.873 19.7%
2013 -47.485.437 62.17%
2014 -30.117.980 -57.66%
2015 -58.587.190 48.59%
2016 -50.771.221 -15.39%
2017 -34.986.432 -45.12%
2018 -12.713.608 -175.19%
2019 -7.162.689 -77.5%
2020 -6.700.606 -6.9%
2021 -13.193.485 49.21%
2022 -4.963.020.000 99.73%
2023 -3.263.956.000 -52.06%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

LadRx Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1987 -17
1988 -49 66.67%
1989 -47 -2.13%
1990 -8 -487.5%
1991 20 140%
1992 -1 0%
1993 -17 100%
1994 -39 56.41%
1995 -57 30.36%
1996 -32 -80.65%
1997 -34 6.06%
1998 -35 2.94%
1999 -83 58.54%
2000 -2 -8100%
2001 -4 66.67%
2002 -16 81.25%
2003 -27 40.74%
2004 -20 -35%
2005 -11 -81.82%
2006 -10 -10%
2007 -11 0%
2008 -12 16.67%
2009 -2 -500%
2010 0 0%
2011 -5 100%
2012 -5 0%
2013 -9 50%
2014 -3 -166.67%
2015 -6 40%
2016 -4 -66.67%
2017 -1 -200%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -114 100%
2023 -7 -1800%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

LadRx Corporation Free Cashflow
Year Free Cashflow Growth
1989 -4.000.000
1990 -1.000.000 -300%
1991 2.500.000 140%
1992 -300.000 933.33%
1993 -5.900.000 94.92%
1994 -11.400.000 48.25%
1995 -8.200.000 -39.02%
1996 -6.600.000 -24.24%
1997 -6.400.000 -3.13%
1998 -6.900.000 7.25%
1999 -14.061.000 50.93%
2000 -1.378.154 -920.28%
2001 1.039.194 232.62%
2002 -3.527.816 129.46%
2003 -4.521.614 21.98%
2004 -13.124.776 65.55%
2005 -62.062.115 78.85%
2006 -31.773.415 -95.33%
2007 -23.623.141 -34.5%
2008 -20.404.270 -15.78%
2009 -12.309.713 -65.76%
2010 -14.859.841 17.16%
2011 -16.724.251 11.15%
2012 -19.186.289 12.83%
2013 -23.792.792 19.36%
2014 -41.512.093 42.68%
2015 -47.913.775 13.36%
2016 -50.870.793 5.81%
2017 -27.332.166 -86.12%
2018 -10.878.957 -151.24%
2019 -5.743.005 -89.43%
2020 -6.166.035 6.86%
2021 -12.315.894 49.93%
2022 -4.832.464.000 99.75%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

LadRx Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 -3.900.000
1990 -1.000.000 -290%
1991 2.600.000 138.46%
1992 0 0%
1993 -2.800.000 100%
1994 -8.500.000 67.06%
1995 -7.900.000 -7.59%
1996 -6.100.000 -29.51%
1997 -6.100.000 0%
1998 -6.900.000 11.59%
1999 -11.546.000 40.24%
2000 -1.350.122 -755.18%
2001 1.039.194 229.92%
2002 -3.527.816 129.46%
2003 -4.293.155 17.83%
2004 -12.353.192 65.25%
2005 -14.499.115 14.8%
2006 9.359.585 254.91%
2007 -22.353.828 141.87%
2008 -19.409.944 -15.17%
2009 -12.114.264 -60.22%
2010 -14.544.090 16.71%
2011 -16.671.383 12.76%
2012 -19.044.650 12.46%
2013 -23.750.983 19.82%
2014 -40.555.807 41.44%
2015 -47.582.447 14.77%
2016 -49.850.352 4.55%
2017 -27.197.568 -83.29%
2018 -10.867.479 -150.27%
2019 -5.718.347 -90.05%
2020 -6.140.133 6.87%
2021 -12.308.890 50.12%
2022 -4.832.464.000 99.75%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

LadRx Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 100.000
1990 0 0%
1991 100.000 100%
1992 300.000 66.67%
1993 3.100.000 90.32%
1994 2.900.000 -6.9%
1995 300.000 -866.67%
1996 500.000 40%
1997 300.000 -66.67%
1998 0 0%
1999 2.515.000 100%
2000 28.032 -8871.89%
2001 0 0%
2002 0 0%
2003 228.459 100%
2004 771.584 70.39%
2005 47.563.000 98.38%
2006 41.133.000 -15.63%
2007 1.269.313 -3140.57%
2008 994.326 -27.66%
2009 195.449 -408.74%
2010 315.751 38.1%
2011 52.868 -497.24%
2012 141.639 62.67%
2013 41.809 -238.78%
2014 956.286 95.63%
2015 331.328 -188.62%
2016 1.020.441 67.53%
2017 134.598 -658.14%
2018 11.478 -1072.66%
2019 24.658 53.45%
2020 25.902 4.8%
2021 7.004 -269.82%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

LadRx Corporation Equity
Year Equity Growth
1987 9.500.000
1988 4.000.000 -137.5%
1989 8.400.000 52.38%
1990 800.000 -950%
1991 22.700.000 96.48%
1992 51.200.000 55.66%
1993 47.700.000 -7.34%
1994 38.000.000 -25.53%
1995 29.800.000 -27.52%
1996 22.300.000 -33.63%
1997 19.800.000 -12.63%
1998 14.700.000 -34.69%
1999 1.033.000 -1323.04%
2000 5.618.814 81.62%
2001 6.582.751 14.64%
2002 7.959.347 17.3%
2003 10.192.616 21.91%
2004 1.595.092 -539%
2005 7.208.362 77.87%
2006 5.150.339 -39.96%
2007 40.224.039 87.2%
2008 15.698.307 -156.23%
2009 28.347.683 44.62%
2010 30.567.975 7.26%
2011 24.254.070 -26.03%
2012 30.165.841 19.6%
2013 10.661.367 -182.95%
2014 67.911.463 84.3%
2015 44.078.998 -54.07%
2016 24.777.284 -77.9%
2017 18.145.055 -36.55%
2018 20.362.299 10.89%
2019 15.204.712 -33.92%
2020 8.870.960 -71.4%
2021 4.776.419 -85.72%
2022 -1.317.964.000 100.36%
2023 965.390.000 236.52%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

LadRx Corporation Assets
Year Assets Growth
1987 11.400.000
1988 12.400.000 8.06%
1989 12.400.000 0%
1990 1.700.000 -629.41%
1991 23.800.000 92.86%
1992 52.800.000 54.92%
1993 49.800.000 -6.02%
1994 38.700.000 -28.68%
1995 31.000.000 -24.84%
1996 24.300.000 -27.57%
1997 24.900.000 2.41%
1998 16.600.000 -50%
1999 6.128.000 -170.89%
2000 6.859.238 10.66%
2001 7.610.596 9.87%
2002 9.283.584 18.02%
2003 12.324.284 24.67%
2004 5.048.756 -144.11%
2005 9.938.910 49.2%
2006 31.636.440 68.58%
2007 64.146.036 50.68%
2008 28.324.030 -126.47%
2009 35.276.889 19.71%
2010 36.697.090 3.87%
2011 37.854.423 3.06%
2012 40.231.499 5.91%
2013 41.499.603 3.06%
2014 85.692.582 51.57%
2015 67.024.438 -27.85%
2016 62.769.784 -6.78%
2017 48.347.519 -29.83%
2018 22.925.639 -110.89%
2019 17.255.018 -32.86%
2020 12.060.227 -43.07%
2021 8.726.777 -38.2%
2022 2.246.772.000 99.61%
2023 3.065.566.000 26.71%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

LadRx Corporation Liabilities
Year Liabilities Growth
1987 1.900.000
1988 8.400.000 77.38%
1989 4.000.000 -110%
1990 900.000 -344.44%
1991 1.100.000 18.18%
1992 1.600.000 31.25%
1993 2.100.000 23.81%
1994 700.000 -200%
1995 1.200.000 41.67%
1996 2.000.000 40%
1997 5.100.000 60.78%
1998 1.900.000 -168.42%
1999 5.095.000 62.71%
2000 1.240.424 -310.75%
2001 1.027.845 -20.68%
2002 1.324.237 22.38%
2003 1.801.381 26.49%
2004 3.282.993 45.13%
2005 2.730.548 -20.23%
2006 26.486.101 89.69%
2007 21.213.629 -24.85%
2008 12.625.723 -68.02%
2009 6.929.206 -82.21%
2010 6.129.115 -13.05%
2011 13.600.353 54.93%
2012 10.065.935 -35.11%
2013 30.838.688 67.36%
2014 17.781.119 -73.44%
2015 22.945.440 22.51%
2016 37.992.500 39.61%
2017 30.202.464 -25.79%
2018 2.563.666 -1078.1%
2019 2.050.306 -25.04%
2020 3.189.267 35.71%
2021 3.950.358 19.27%
2022 2.221.052.000 99.82%
2023 2.100.176.000 -5.76%

LadRx Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-7.32
Price to Earning Ratio
-0.01x
Price To Sales Ratio
0x
POCF Ratio
-0.01
PFCF Ratio
0
Price to Book Ratio
0.05
EV to Sales
0
EV Over EBITDA
0.37
EV to Operating CashFlow
0.52
EV to FreeCashFlow
0.52
Earnings Yield
-81.34
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
-2,85 Bil.
Graham Number
17.92
Graham NetNet
1.68

Income Statement Metrics

Net Income per Share
-7.32
Income Quality
1.05
ROE
-6.85
Return On Assets
-11.11
Return On Capital Employed
-0.05
Net Income per EBT
1
EBT Per Ebit
215.44
Ebit per Revenue
-216.1
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.64
Operating Profit Margin
-216.1
Pretax Profit Margin
-46557.81
Net Profit Margin
-46557.81

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.17
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-11.15
Free CashFlow per Share
-11.15
Capex to Operating CashFlow
-0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-6.91
Return on Tangible Assets
-1.18
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
5,92
Book Value per Share
1,95
Tangible Book Value per Share
1.95
Shareholders Equity per Share
1.95
Interest Debt per Share
0.3
Debt to Equity
0.09
Debt to Assets
0.03
Net Debt to EBITDA
0.37
Current Ratio
1.41
Tangible Asset Value
0,97 Bil.
Net Current Asset Value
0,87 Bil.
Invested Capital
0.09
Working Capital
0,87 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
1,02 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

LadRx Corporation Dividends
Year Dividends Growth
2008 0

LadRx Corporation Profile

About LadRx Corporation

LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

CEO
Mr. Steven Kriegsman
Employee
3
Address
11726 San Vicente Blvd Ste 650
Los Angeles, 90049

LadRx Corporation Executives & BODs

LadRx Corporation Executives & BODs
# Name Age
1 Dr. Stephen Snowdy Ph.D.
Chief Executive Officer
70
2 Molly Carey Poarch
Global & U.S. Head of Corporation Communications
70
3 Ms. Molly Painter
Pres of USA and Head of Launch & Commercial Operations
70
4 Terri Stevens
Chief Bus. Officer
70
5 Ms. Cristina Newman
Corporation Sec.
70
6 Mr. John Y. Caloz
Chief Financial Officer, Treasurer & Senior Vice President
70
7 Dr. Felix Kratz Ph.D.
Senior Vice President, Drug Devel.
70

LadRx Corporation Competitors